CONCLUSION
Overall, we identify significant racial/ethnic disparities in survival
among those diagnosed with pediatric brain and CNS tumors, with Hispanic
patients having the highest risk of mortality, even after accounting for
stage of diagnosis, tumor grade, and SES. The observed differences in
survival become more pronounced with increasing follow up time.
Eliminating these disparities requires commitment towards promoting
equity in healthcare delivery. Future studies aimed at delineating how
differences in host and tumor genetic factors impact treatment response
could help optimize treatment for patients including offering
personalized cancer treatment.
CONFLICTS OF INTEREST :
There are no financial disclosures or conflicts of interest to report.